DBD - Laboratory and Epidemiology Support Services for Pneumonia, Streptococcus, and Atypical Bacteria

The contract encompasses laboratory and epidemiology support services focused on pneumonia, Streptococcus, and atypical bacteria, with a base performance period running from September 29, 2024, to September 28, 2025, and four optional one-year extensions through September 28, 2029, bringing the potential total duration to five years. The total contract value across all tasks is capped at $23,000,000, with consideration for the award tied to EGS. The work is being procured by the Centers for Disease Control and Prevention under NAICS code 541380, and the primary point of contact for program-related inquiries is Theresa Kanter, reachable via tjk9@cdc.gov, while the contracting officer position remains to be filled. Performance locations and specific office addresses are not detailed in the provided data.